Literature DB >> 4025307

Mortality of lead smelter workers.

S G Selevan, P J Landrigan, F B Stern, J H Jones.   

Abstract

To examine patterns of death in lead smelter workers, a retrospective analysis of mortality was conducted in a cohort of 1,987 males employed between 1940 and 1965 at a primary lead smelter in Idaho. Overall mortality was similar to that of the United States white male population (standardized mortality ratio (SMR) = 98). Excess mortality, however, was found from chronic renal disease (SMR = 192; confidence interval (CI) = 88-364), and the risk of death from renal disease increased with increasing duration of employment, such that after 20 years employment, the standardized mortality ratio reached 392 (CI = 107-1,004). Excess mortality was also noted for nonmalignant respiratory disease (SMR = 187, CI = 128-264). Eight of 32 deaths in this category were caused by silicosis; at least five workers who died of silicosis had been miners for a part of their lives. An additional 11 deaths resulted from tuberculosis (SMR = 139; CI = 69-249); in six of these cases, silicosis was a contributory cause of death. Cancer mortality was not increased overall (SMR = 95; CI = 78-114). An increase, however, was noted for deaths from kidney cancer (six cases; SMR = 204; CI = 75-444). Finally, excess mortality was noted for injuries (SMR = 138; CI = 104-179); 13 (23%) of the 56 deaths in this category were caused by mining injuries. The data from this study are consistent with previous reports of increased mortality from chronic renal disease in persons exposed occupationally to lead.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025307     DOI: 10.1093/oxfordjournals.aje.a114146

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  34 in total

1.  Reappraisal of the relation between blood lead concentration and blood pressure among the general population in Taiwan.

Authors:  N F Chu; S H Liou; T N Wu; P Y Chang
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

Review 2.  Lead intoxication--new insights into an old problem.

Authors:  R Nowack; E Ritz
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

3.  Mortality of lead smelter workers: A follow-up study with exposure assessment.

Authors:  Stephen J Bertke; Everett J Lehman; Steven J Wurzelbacher; Misty J Hein
Journal:  Am J Ind Med       Date:  2016-06-28       Impact factor: 2.214

4.  Risk factors for high blood lead levels among the general population in Taiwan.

Authors:  N F Chu; S H Liou; T N Wu; K N Ko; P Y Chang
Journal:  Eur J Epidemiol       Date:  1998-12       Impact factor: 8.082

5.  More evidence of unpublished industry studies of lead smelter/refinery workers.

Authors:  Marianne Sullivan
Journal:  Int J Occup Environ Health       Date:  2015-06-12

Review 6.  Toxicity of lead at low dose.

Authors:  P J Landrigan
Journal:  Br J Ind Med       Date:  1989-09

7.  Occupational lead exposure and blood pressure.

Authors:  D K Parkinson; M J Hodgson; E J Bromet; M A Dew; M M Connell
Journal:  Br J Ind Med       Date:  1987-11

8.  Renal function and hyperfiltration capacity in lead smelter workers with high bone lead.

Authors:  H Roels; R Lauwerys; J Konings; J P Buchet; A Bernard; S Green; D Bradley; W Morgan; D Chettle
Journal:  Occup Environ Med       Date:  1994-08       Impact factor: 4.402

9.  Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data.

Authors:  H Fu; P Boffetta
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

10.  Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.

Authors:  Christine Neslund-Dudas; Albert M Levin; Jennifer L Beebe-Dimmer; Cathryn H Bock; Nora L Nock; Andrew Rundle; Michelle Jankowski; Richard Krajenta; Q Ping Dou; Bharati Mitra; Deliang Tang; Timothy R Rebbeck; Benjamin A Rybicki
Journal:  Cancer Causes Control       Date:  2014-05-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.